Not known Details About Sulfoxaflor
All enrolled people who received at least one particular dose of zosuquidar or placebo for the duration of induction were being monitored for your incidence of adverse occasions (439 sufferers, 219 on zosuquidar and 210 on placebo). The most typical adverse situations were connected with the period of extended and significant myelosuppression as is